chr3-69119929-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_198271.5(LMOD3):​c.426A>C​(p.Glu142Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00326 in 1,558,826 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. E142E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0022 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0034 ( 16 hom. )

Consequence

LMOD3
NM_198271.5 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.307

Publications

3 publications found
Variant links:
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
  • nemaline myopathy 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • typical nemaline myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • severe congenital nemaline myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004485756).
BP6
Variant 3-69119929-T-G is Benign according to our data. Variant chr3-69119929-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00225 (342/152278) while in subpopulation NFE AF = 0.00396 (269/68014). AF 95% confidence interval is 0.00357. There are 0 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 16 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_198271.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMOD3
NM_198271.5
MANE Select
c.426A>Cp.Glu142Asp
missense
Exon 2 of 3NP_938012.2
LMOD3
NM_001304418.3
c.426A>Cp.Glu142Asp
missense
Exon 3 of 4NP_001291347.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LMOD3
ENST00000420581.7
TSL:1 MANE Select
c.426A>Cp.Glu142Asp
missense
Exon 2 of 3ENSP00000414670.3
LMOD3
ENST00000475434.1
TSL:5
c.426A>Cp.Glu142Asp
missense
Exon 3 of 4ENSP00000418645.1
LMOD3
ENST00000489031.5
TSL:2
c.426A>Cp.Glu142Asp
missense
Exon 3 of 4ENSP00000417210.1

Frequencies

GnomAD3 genomes
AF:
0.00224
AC:
341
AN:
152160
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000965
Gnomad AMI
AF:
0.00329
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00170
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00394
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.00197
AC:
337
AN:
171080
AF XY:
0.00210
show subpopulations
Gnomad AFR exome
AF:
0.000524
Gnomad AMR exome
AF:
0.000513
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00146
Gnomad NFE exome
AF:
0.00339
Gnomad OTH exome
AF:
0.00297
GnomAD4 exome
AF:
0.00337
AC:
4739
AN:
1406548
Hom.:
16
Cov.:
30
AF XY:
0.00333
AC XY:
2313
AN XY:
695046
show subpopulations
African (AFR)
AF:
0.000655
AC:
21
AN:
32066
American (AMR)
AF:
0.000442
AC:
16
AN:
36222
Ashkenazi Jewish (ASJ)
AF:
0.0000792
AC:
2
AN:
25240
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36800
South Asian (SAS)
AF:
0.00165
AC:
133
AN:
80622
European-Finnish (FIN)
AF:
0.00155
AC:
78
AN:
50386
Middle Eastern (MID)
AF:
0.00140
AC:
8
AN:
5702
European-Non Finnish (NFE)
AF:
0.00399
AC:
4309
AN:
1081136
Other (OTH)
AF:
0.00295
AC:
172
AN:
58374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
218
435
653
870
1088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00225
AC:
342
AN:
152278
Hom.:
0
Cov.:
31
AF XY:
0.00215
AC XY:
160
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000962
AC:
40
AN:
41562
American (AMR)
AF:
0.000196
AC:
3
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4832
European-Finnish (FIN)
AF:
0.00170
AC:
18
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00396
AC:
269
AN:
68014
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00898
Hom.:
9
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00415
AC:
16
ExAC
AF:
0.00120
AC:
139

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 29923248)

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LMOD3: BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
May 06, 2020
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nemaline myopathy 10 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LMOD3-related disorder Benign:1
Jul 19, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
12
DANN
Uncertain
0.98
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.64
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.46
T
M_CAP
Benign
0.043
D
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-0.46
T
MutationAssessor
Benign
1.9
M
PhyloP100
0.31
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.12
Sift
Benign
0.070
T
Sift4G
Benign
0.17
T
Polyphen
0.0020
B
Vest4
0.075
MutPred
0.44
Gain of glycosylation at S137 (P = 0.0035)
MVP
0.79
MPC
0.020
ClinPred
0.0014
T
GERP RS
1.3
Varity_R
0.082
gMVP
0.035
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111848977; hg19: chr3-69169080; API